Gujarat Themis Biosyn Limited (NSE:GUJTHEM)
India · Delayed Price · Currency is INR 419.30
+8.55 (2.08%)
Sep 24, 2026, 11:10 AM IST
Gujarat Themis Biosyn Employees
Gujarat Themis Biosyn had 221 employees as of March 31, 2025. The number of employees increased by 62 or 38.99% compared to the previous year.
Employees
221
Change (1Y)
62
Growth (1Y)
38.99%
Revenue / Employee
7.86M INR
Profits / Employee
2.20M INR
Market Cap
53.37B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 221 | 62 | 38.99% |
| Mar 31, 2024 | 159 | 50 | 45.87% |
| Mar 31, 2023 | 109 | 4 | 3.81% |
| Mar 31, 2022 | 105 | -2 | -1.87% |
| Mar 31, 2021 | 107 | 6 | 5.94% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Indoco Remedies | 6,000 |
| Strides Pharma Science | 3,535 |
| Aarti Pharmalabs | 2,421 |
| Solara Active Pharma Sciences | 1,669 |
| Ind-Swift Laboratories | 1,388 |
| Windlas Biotech | 1,385 |
| RPG Life Sciences | 1,366 |
| Orchid Pharma | 1,169 |
Gujarat Themis Biosyn News
- 4 months ago - Gujarat Themis Biosyn shares jump 5% after signing Rs 1,300 crore deal to acquire Japan’s Microbiopharm entity - Business Upturn
- 11 months ago - Gujarat Themis Biosyn begins commercial production after major capacity expansion at Vapi facility - Business Upturn
- 1 year ago - Gujarat Themis Biosyn starts commercial production at new API plant in Vapi, Gujarat - Business Upturn
- 1 year ago - Themis Medicare shares surge nearly 2% following amalgamation announcement - Business Upturn